___

• 1. Asbury A, Cornblath DR. Assesment of current diagnostic criteria for Guillain-Barre Syndrome. Ann Neurol 1990; 27 (Suppl): 21-24.
• 2. Menkes HJ: Immunologically mediated demyelinating diseases of the periferal nervous system, Guillain-Barre Syndrome. In: Menkes HJ, Sarnat BH eds. Textbook of Child Neurology. Philadelphia: Lippincott Williams and Wilkins, 2000: 658-65.
• 3. Rantala H, Uhari M, Niemela M. Occurence, clinical manifestations, and prognosis of Guillain-Barre Syndrome, Arch Dis Child 1991; 66:706.
• 4. Yuki N, Ang CW, Koga M, et al. Clinical features and response to treatment in Guillain-Barre Syndrome assosiated with antibodies to GM1b ganglioside Ann Neurol 2000; 47:314-21.
• 5. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997; 745: 32-6.
• 6. Ryan MM. Guillain-Barre Syndrome in childhood. Rewiev Article. J Paediatr Child Health (2005) 41, 237-41.
• 7. Visser LH, van der Meche FG, Meulstee J et al. Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 1996; 47: 668-73.
• 8. Delanoe C, Sebire G, Landrieu P, Huault G, Metral S. Acute inflammatory demyelinating polyradiculopathy in children: Clinical and electrodiagnostic studies. Ann Neurol 1998; 44: 350-56.
• 9. Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain Barre syndrome. A multicentre prospective study of 297 patients. Brain 1996; 119:2053.
• 10. Bradshaw DY, Jones HR Jr. Guillain-Barre syndrome in children: Clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992; 15: 500-6.
• 11. Jones HR. Childhood Guillain-Barre syndrome: Clinical presentation, diagnosis, and therapy. J Child Neurol 1996; 11: 4-12.
• 12. Moulin DE, Hagen N, Feasby TE, et al. Pain in Guillain-Barre syndrome. Neurology, 1997; 48: 328.
• 13. Larsen A, Tobias JD. Landry- Guillain-Barre syndrome presenting with symptoms of upper airway obstruction. Pediatr Emerg Care 1994; 10: 347-8.
• 14. Briscoe DM, Mc Menamin JB, O'Donohoe NV. Prognosis in GuillainBarre syndrome Arch Dis Child 1987; 62: 733.
• 15. Grattan-Smith PJ, Morris JG, Johnston HM et al. Clinical and neurophysiological features of tick paralysis. Brain 1997; 120: 1975-87.
• 16. Swaiman KF: Inflammatory Neuropathies in Childhood. In: Swaiman KF, Ashwal S. eds Textbook of Pediatric Neurology, Principles and Practice, St Louis: Mosby, 1999: 1201-09.
• 17. Feasby TE, et al. Severe axonal degeneration in acute Guillain-Barre syndrome: evidence of two different mechanisms? J Neurol Sci 1993; 116:185-92.
• 18. Coflkun A, Kumandas S, Pac A et al. Childhood Guillain-Barre syndrome MR imaging in diagnosis and follow-up. Acta Radiol 2003; 44: 230- 35.
• 19. Knebusch M, Strassburg HM, Reiners K. Acute transverse myelitis in childhood: Nine cases and review of the literature. Dev Med Child Neurol 1998; 40: 631-39.
• 20. Ropper AH, Kehne SM. Guillain-Barre syndrome: Management of respiratory failure. Neurology 1985; 35: 1662-65.
• 21. Ropper AH, Shahani BT. Pain in Guillain-Barre syndrome. Arch Neurol 1984; 41: 511-14.
• 22. Haupt WF. Recent Advances of Therapeutic Apheresis in Guillain-Barre syndrome. Therapeutic Apheresis 2000; 4 (4): 271-74.
• 23. Plasma Exchange/Sandoglobulin Guillain-Barre syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 1997; 349: 225.